Literature DB >> 9282851

Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor.

R C Wallace1, A J Furlan, D J Moliterno, G H Stevens, T J Masaryk, J Perl.   

Abstract

We describe the use of abciximab to prevent rethrombosis of the basilar artery after transluminal angioplasty. A 60-year-old patient with vertebral basilar insufficiency and acute occlusion of the basilar artery underwent revascularization with urokinase and angioplasty. Despite the repeated use of urokinase and angioplasty under anticoagulation with heparin, the basilar artery immediately rethrombosed. In a final attempt to prevent rethrombosis, abciximab was administered before the final angioplasty, resulting in a widely patent basilar artery and no rethrombosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282851      PMCID: PMC8338011     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  18 in total

1.  Use of glycoprotein IIb-IIIa inhibitor for a thromboembolic complication during Guglielmi detachable coil treatment of an acutely ruptured aneurysm.

Authors:  P P Ng; C C Phatouros; M S Khangure
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

2.  Outcome of acute vertebrobasilar occlusions treated with intra-arterial fibrinolysis in 180 patients.

Authors:  G Schulte-Altedorneburg; G F Hamann; M Mull; D Kühne; M Liebetrau; W Weber; H Brückmann; T E Mayer
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 3.  [Diagnosis and therapy of basilar artery occlusion].

Authors:  T Pfefferkorn; T E Mayer; G Schulte-Altedorneburg; H Brückmann; G F Hamann; M Dichgans
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

4.  Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases.

Authors:  O-Ki Kwon; Ki Jae Lee; Moon Hee Han; Chang-Wan Oh; Dae Hee Han; Young Cho Koh
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

5.  Safety of abciximab administration during PCI of patients with previous stroke.

Authors:  Efthymios N Deliargyris; Bharathi Upadhya; Robert J Applegate; Jimmy L Kontos; Michael A Kutcher; Jeffrey S Riesmeyer; David C Sane
Journal:  J Thromb Thrombolysis       Date:  2005-06       Impact factor: 2.300

6.  Abciximab in patients with ruptured intracranial aneurysms.

Authors:  Richard I Aviv; Richard O'Neill; Maneesh C Patel; Iain R Colquhoun
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

7.  Treatment of vertebrobasilar occlusion by using a coronary waterjet thrombectomy device: a pilot study.

Authors:  Thomas E Mayer; Gerhard F Hamann; Gernot Schulte-Altedorneburg; Hartmut Brückmann
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

Review 8.  Is eptifibatide a safe and effective rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization? Single-center experience in 42 cases and review of the literature.

Authors:  Jacques Sedat; Yves Chau; Lydiane Mondot; Richard Chemla; Michel Lonjon; Bernard Padovani
Journal:  Neuroradiology       Date:  2013-11-27       Impact factor: 2.804

9.  Thrombolytic Therapy in Acute Ischemic Stroke.

Authors:  Anthony J. Furlan; Irene L. Katzan; Louis R. Caplan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-07

Review 10.  Acute stroke therapy 1981-2009.

Authors:  Bernd Eckert
Journal:  Klin Neuroradiol       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.